Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
<h4>Introduction</h4>Complete and understandable information is vital for informed consent and this includes how and when potential participants can expect to receive trial results. Informing participants during informed consent about the sharing of trial results is important for address...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0268898 |
| _version_ | 1818048566619275264 |
|---|---|
| author | Matilda Bjorklund Frances Shiely Katie Gillies |
| author_facet | Matilda Bjorklund Frances Shiely Katie Gillies |
| author_sort | Matilda Bjorklund |
| collection | DOAJ |
| description | <h4>Introduction</h4>Complete and understandable information is vital for informed consent and this includes how and when potential participants can expect to receive trial results. Informing participants during informed consent about the sharing of trial results is important for addressing participants' needs, ensuring adherence to regulatory guidance, and in fulfilling a moral obligation.<h4>Methods</h4>Patient Information Leaflets (PILs) were collated from across the UK and Ireland. Trial characteristics and data on disseminating trial results was extracted. Analysis included descriptive statistics and a directed content analysis approach. The content analysis framework was informed by regulatory guidance on PIL content and existing research on dissemination of trial results. Results were analysed using descriptive statistics and presented as a narrative summary as appropriate.<h4>Results</h4>238 PILs from 178 trials were analysed. Of the 238 PILs, 74% (n = 176) provided information on sharing results with participants, 70% (n = 123) of which described passive methods of disseminating results that require active engagement from the trial participants, i.e., effort required by the participant to seek the results. The majority (90%) of PILs included more than one proposed mode of dissemination that largely targeted healthcare professionals rather than participants. Only 8% of PILs specified a time period for when results could be expected, 47% did not specify a time period (e.g. at end of trial), and 45% included no information on when trial results would be available.<h4>Conclusion</h4>This study found that majority of the PILs included did include some information about dissemination of trial results. However, modes of dissemination tended to target researchers and clinicians rather than participants and information on when results would be available was often lacking. The findings highlight the need for further research that includes stakeholder input to identify what information on results summaries participants need at the point of making a decision about trial participation. |
| first_indexed | 2024-12-10T10:23:43Z |
| format | Article |
| id | doaj.art-9751dc0cc77d4be78ec2cb5f4579a56d |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T10:23:43Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-9751dc0cc77d4be78ec2cb5f4579a56d2022-12-22T01:52:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01175e026889810.1371/journal.pone.0268898Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.Matilda BjorklundFrances ShielyKatie Gillies<h4>Introduction</h4>Complete and understandable information is vital for informed consent and this includes how and when potential participants can expect to receive trial results. Informing participants during informed consent about the sharing of trial results is important for addressing participants' needs, ensuring adherence to regulatory guidance, and in fulfilling a moral obligation.<h4>Methods</h4>Patient Information Leaflets (PILs) were collated from across the UK and Ireland. Trial characteristics and data on disseminating trial results was extracted. Analysis included descriptive statistics and a directed content analysis approach. The content analysis framework was informed by regulatory guidance on PIL content and existing research on dissemination of trial results. Results were analysed using descriptive statistics and presented as a narrative summary as appropriate.<h4>Results</h4>238 PILs from 178 trials were analysed. Of the 238 PILs, 74% (n = 176) provided information on sharing results with participants, 70% (n = 123) of which described passive methods of disseminating results that require active engagement from the trial participants, i.e., effort required by the participant to seek the results. The majority (90%) of PILs included more than one proposed mode of dissemination that largely targeted healthcare professionals rather than participants. Only 8% of PILs specified a time period for when results could be expected, 47% did not specify a time period (e.g. at end of trial), and 45% included no information on when trial results would be available.<h4>Conclusion</h4>This study found that majority of the PILs included did include some information about dissemination of trial results. However, modes of dissemination tended to target researchers and clinicians rather than participants and information on when results would be available was often lacking. The findings highlight the need for further research that includes stakeholder input to identify what information on results summaries participants need at the point of making a decision about trial participation.https://doi.org/10.1371/journal.pone.0268898 |
| spellingShingle | Matilda Bjorklund Frances Shiely Katie Gillies Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when. PLoS ONE |
| title | Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when. |
| title_full | Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when. |
| title_fullStr | Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when. |
| title_full_unstemmed | Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when. |
| title_short | Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when. |
| title_sort | information about dissemination of trial results in patient information leaflets for clinicals trials in the uk and ireland the what and the when |
| url | https://doi.org/10.1371/journal.pone.0268898 |
| work_keys_str_mv | AT matildabjorklund informationaboutdisseminationoftrialresultsinpatientinformationleafletsforclinicalstrialsintheukandirelandthewhatandthewhen AT francesshiely informationaboutdisseminationoftrialresultsinpatientinformationleafletsforclinicalstrialsintheukandirelandthewhatandthewhen AT katiegillies informationaboutdisseminationoftrialresultsinpatientinformationleafletsforclinicalstrialsintheukandirelandthewhatandthewhen |